Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Baftiu A, Johannessen Landmark C, Rusten IR, Feet SA, Johannessen SI, Larsson PG (2016) Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders – a pharmacoepidemiological study and clinical implications. Eur J Clin Pharmacol 72:1245–1254
Ben-Menachem E, Biton V, Jatuzis D, Abou-Khalil B, Doty P, Rudd GD (2007) Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 48:1308–1317
Beydoun A (1999) Monotherapy trials with gabapentin for partial epilepsy. Epilepsia 40(Suppl 6):S13–S16
Bresnahan R, Hounsome J, Jette N, Hutton JL, Marson AG (2019a) Topiramate add-on therapy for drug-resistant focal epilepsy. Cochrane Database Syst Rev 10:CD1417. https://doi.org/10.1002/14651858.CD001417.pub4
Bresnahan R, Panebianco M, Marson AG (2019b) Brivaracetam add-on therapy for drug-resistant epilepsy. Cochrane Database Syst Rev 3:CD11501. https://doi.org/10.1002/14651858.CD011501.pub2
Brodie MJ (2004) Pregabalin as adjunctive therapy for partial seizures. Epilepsia 45(Suppl 6):19–27
Brodie MJ (2006) Zonisamide as adjunctive therapy for refractory partial seizures. Epilepsy Res 68(Suppl 2):S11–S16
Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ (2007) Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Baillieres Clin Neurol 68:402–408
Costa J, Fareleira F, Ascenção R, Borges M, Sampaio C, Vaz-Carneiro A (2011) Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis. Epilepsia 52:1280–1291
Deutsche Gesellschaft für Neurologie (2017) Leitlinien für Diagnostik und Therapie in der Neurologie. Erster epileptischer Anfall und Epilepsien im Erwachsenenalter. https://www.dgn.org/leitlinien
Dooley M, Plosker GL (2000) Levetiracetam. A review of its adjunctive use in the management of partial onset seizures. Drugs 60:871–893
Elger C, Halasz P, Maia J, Almeida L, Soares-da-Silva P (2009) Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study. Epilepsia 50:454–463
Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpää M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice AS, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M (2015) Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 14:162–173
French JA, Krauss GL, Wechsler RT, Wang XF, DiVentura B, Brandt C et al (2015) Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy a randomized trial. Neurology 85:950–957
Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M (1998) Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 280:1831–1836
Goa KL, Ross SR, Chrisp P (1993) Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 46:152–176
Helmstaedter C, Fritz NE, Kockelmann E, Kosanetzky N, Elger CE (2008) Positive and negative psychotropic effects of levetiracetam. Epilepsy Behav 13:535–541
Hitiris N, Brodie MJ (2006) Modern antiepileptic drugs: guidelines and beyond. Curr Opin Neurol 19:175–180
Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J (2018) Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs I: treatment of new-onset epilepsy: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 91:74–81
Koch MW, Polman SK (2009) Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures. Cochrane Database Syst Rev 4:CD6453
Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G et al (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51:1069–1077
LaRoche SM, Helmers SL (2004) The new antiepileptic drugs: scientific review. JAMA 291:605–614
Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. PNAS 101:9861–9866
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G et al (2021a) The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet 397:1363–1374
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G et al (2021b) The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet 397:1375–1386
Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJL, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DS, Smith PEM, Tudor Smith C, Vanoli A, Williamson PR (2007a) The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 369:1000–1015
Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJL, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DS, Smith PEM, Tudor Smith C, Vanoli A, Williamson PR (2007b) The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalized and unclassifiable epilepsy: an unblinded randomized controlled trial. Lancet 369:1016–1026
Mbizvo GK, Dixon P, Hutton JL, Marson AG (2012) Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane review. Cochrane Database Syst Rev 9:CD1901
Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ (2009) Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev 3:CD7076
Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA (1999) Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 159:1931–1937
National Institute for Health and Care Excellence (NICE) (2018) Epilepsies: the diagnosis and management. Clinical guideline CG137. https://www.nice.org.uk/guidance/cg137 (Erstellt: 04.2018)
Nevitt SJ, Tudur Smith C, Weston J, Marson AG (2018) Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review. Cochrane Database Syst Rev 6:CD1031
Nunes VD, Sawyer L, Neilson J, Sarri G, Cross JH (2013) Profile of lacosamide and its role in the long-term treatment of epilepsy: a perspective from the updated NICE guideline. Neuropsychiatr Dis Treat 9:467–476
Perucca E, Yasothan U, Clincke G, Kirkpatrick P (2008) Lacosamide. Nat Rev Drug Discov 7:973–974
Steinhoff BJ, Ben-Menachem E, Ryvlin P, Shorvon S, Kramer L, Satlin A et al (2013) Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies. Epilepsia 54:1481–1489
Stephen LJ, Brodie MJ (2017) Brivaracetam: a novel antiepileptic drug for focal-onset seizures. Ther Adv Neurol Disord 11:1756285617742081
Thijs RD, Surges R, O’Brien TJ, Sander JW (2019) Epilepsy in adults. Lancet 393:689–701
Tomson T, Battino D, Perucca E (2016) Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug. Lancet Neurol 15:210–218
Veroniki AA, Cogo E, Rios P, Straus SE, Finkelstein Y, Kealey R, Reynen E, Soobiah C, Thavorn K, Hutton B, Hemmelgarn BR, Yazdi F, D’Souza J, MacDonald H, Tricco AC (2017) Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med 15:95
Yates SL, Fakhoury T, Liang W, Eckhardt K, Borghs S, D’Souza J (2015) An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam. Epilepsy Behav 52(Pt A):165–168
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Der/die Autor(en), exklusiv lizenziert durch Springer-Verlag GmbH, DE, ein Teil von Springer Nature
About this chapter
Cite this chapter
Seifert, R., Brandt, C. (2021). Antiepileptika. In: Ludwig, WD., Mühlbauer, B., Seifert, R. (eds) Arzneiverordnungs-Report 2021. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-63825-5_15
Download citation
DOI: https://doi.org/10.1007/978-3-662-63825-5_15
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-63824-8
Online ISBN: 978-3-662-63825-5
eBook Packages: Medicine (German Language)